Immunotherapy of Liver Diseases

Immunotherapy of Liver Diseases

Bibliographic Details
Main Authors:	Dechun Feng, YinYing Lu, Xiaoni Kong, Feng Li
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2019/9343505

Similar Items

Interleukin-22 in the pathogenesis and potential treatment of liver diseases
by: Shi Yin, et al.
Published: (2017-09-01)

The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Dechun Feng
Published: (2020-03-01)

Inflammation in Liver Diseases
by: Dechun Feng, et al.
Published: (2018-01-01)

Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives
by: Yuling Luan, et al.
Published: (2021-06-01)

Liver transplantation for liver cancer in the era of immunotherapy
by: LI Zhao
Published: (2021-02-01)

Cellular based immunotherapy for primary liver cancer
by: Yuanyuan Zheng, et al.
Published: (2021-08-01)

Immunotherapy for acute-on-chronic liver failure
by: HAN Ying, et al.
Published: (2017-09-01)

Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
by: Naomi Richardson, et al.
Published: (2020-07-01)

Functional roles of CCL5/RANTES in liver disease
by: Lili Chen, et al.
Published: (2020-03-01)

Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
by: Hua Wang, Fouad Lafdil, Xiaoni Kong, Bin Gao
Published: (2011-01-01)

Immunotherapy for Alzheimer's disease: enlightenment to neurodegenerative diseases
by: Ying ZHANG
Published: (2014-04-01)

Emerging roles of DJ-1 in liver diseases through regulation of oxidative stress and immune response
by: Min Xu, et al.
Published: (2018-06-01)

Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
by: Huiya Huang, et al.
Published: (2019-10-01)

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
by: Yu X, et al.
Published: (2020-11-01)

Progress in immunotherapy and molecular therapy for liver failure
by: XI Dong, et al.
Published: (2015-09-01)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
by: Pingyi Liu, et al.
Published: (2018-01-01)

The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
by: Dongwei Xu, et al.
Published: (2019-01-01)

Immunotherapy in Myeloproliferative Diseases
by: Lukas M. Braun, et al.
Published: (2020-06-01)

Immunotherapy for Parkinson’s disease
by: Aaron D. Schwab, et al.
Published: (2020-04-01)

Immunotherapies for Neurodegenerative Diseases
by: Ibrahim Mortada, et al.
Published: (2021-06-01)

The immunotherapy of Alzheimer's disease
by: Weksler Marc E
Published: (2004-11-01)

Immunotherapy of Crohn's disease
by: C. van Montfrans, et al.
Published: (1998-01-01)

Immunotherapy for liver tumors: present status and future prospects
by: Gidekel Manuel, et al.
Published: (2009-03-01)

Immunological changes after immunotherapy in asthma patients
by: Lu, Feng Mei, et al.
Published: (1995)

Cytokines and STATs in liver fibrosis
by: Xiaoni eKong, et al.
Published: (2012-04-01)

Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives
by: Ling Chang, et al.
Published: (2020-03-01)

Emerging Immunotherapies for Parkinson Disease
by: Samis M. A. Zella, et al.
Published: (2018-12-01)

Specific immunotherapy for allergic diseases
by: Ariyanto Harsono
Published: (2016-10-01)

Immunotherapy against Prion Disease
by: Yue Ma, et al.
Published: (2020-03-01)

Vaccine Immunotherapy for Celiac Disease
by: Antonio Di Sabatino, et al.
Published: (2018-06-01)

Cancer neoantigen: Boosting immunotherapy
by: Peijia Xu, et al.
Published: (2020-11-01)

Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy
by: Feng Xie, et al.
Published: (2019-02-01)

Immunotherapy of childhood Sarcomas
by: Stephen S Roberts, et al.
Published: (2015-08-01)

Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production
by: Wang Hua, et al.
Published: (2011-04-01)

The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
by: Malek Kreidieh, et al.
Published: (2019-01-01)

Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases
by: Kenji Ina, et al.
Published: (2016-04-01)

Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
by: Valentina Cazzetta, et al.
Published: (2021-05-01)

A race to uncover a panoramic view of primary liver cancer
by: Ruidong Xue, et al.
Published: (2017-08-01)

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
by: Yuehong Chen, et al.
Published: (2019-01-01)

Advances in the treatment of nonalcoholic fatty liver disease
by: FENG Gong
Published: (2017-12-01)